台湾冠心病患者无泵冠状动脉旁路移植术后的长期生存率

Chia-Chun Hung , Chung-Yi Chang , Ming-Chon Hsiung , Jeng Wei
{"title":"台湾冠心病患者无泵冠状动脉旁路移植术后的长期生存率","authors":"Chia-Chun Hung ,&nbsp;Chung-Yi Chang ,&nbsp;Ming-Chon Hsiung ,&nbsp;Jeng Wei","doi":"10.1016/j.ahr.2023.100152","DOIUrl":null,"url":null,"abstract":"<div><p>The study analyzed the long-term survival of 1,482 eligible patients with coronary artery disease who received on-pump coronary artery bypass grafting (ONCAB) between 1997 and 2003 in Taiwan. The cumulative all-cause death rate over 23 years was 21.9%, while the cumulative cardiovascular-specific death (CVD) rate was 2.09%. Patients aged ≥ 70 years had a significantly higher incidence rate ratio (IRR) (IRR, 2.183, 95% confidence interval [CI], 1.742–2.731), but the lower cumulative incidence rate ratio (CIRR) (CIRR, 0.634, 95% CI, 0.524–0.767) for all-cause deaths than those aged &lt; 70 years. There was no significant difference for IRR and CIRR of CVD between 2 groups. Overall survival was influenced by hypertension (hazard ratio [HR], 1.412, 95% CI, 1.104–1.806), dyslipidemia (HR, 1.890, 95% CI, 1.506–2.372), and previous stroke (HR, 0.525, 95% CI, 0.391–0.705) in all patients. Our results suggest that ONCAB may be a viable option for older patients.</p></div>","PeriodicalId":72129,"journal":{"name":"Aging and health research","volume":"3 3","pages":"Article 100152"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Long-term survival after on-pump coronary artery bypass grafting in patients with coronary artery disease in Taiwan\",\"authors\":\"Chia-Chun Hung ,&nbsp;Chung-Yi Chang ,&nbsp;Ming-Chon Hsiung ,&nbsp;Jeng Wei\",\"doi\":\"10.1016/j.ahr.2023.100152\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The study analyzed the long-term survival of 1,482 eligible patients with coronary artery disease who received on-pump coronary artery bypass grafting (ONCAB) between 1997 and 2003 in Taiwan. The cumulative all-cause death rate over 23 years was 21.9%, while the cumulative cardiovascular-specific death (CVD) rate was 2.09%. Patients aged ≥ 70 years had a significantly higher incidence rate ratio (IRR) (IRR, 2.183, 95% confidence interval [CI], 1.742–2.731), but the lower cumulative incidence rate ratio (CIRR) (CIRR, 0.634, 95% CI, 0.524–0.767) for all-cause deaths than those aged &lt; 70 years. There was no significant difference for IRR and CIRR of CVD between 2 groups. Overall survival was influenced by hypertension (hazard ratio [HR], 1.412, 95% CI, 1.104–1.806), dyslipidemia (HR, 1.890, 95% CI, 1.506–2.372), and previous stroke (HR, 0.525, 95% CI, 0.391–0.705) in all patients. Our results suggest that ONCAB may be a viable option for older patients.</p></div>\",\"PeriodicalId\":72129,\"journal\":{\"name\":\"Aging and health research\",\"volume\":\"3 3\",\"pages\":\"Article 100152\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Aging and health research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667032123000367\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aging and health research","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667032123000367","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

该研究分析了1997年至2003年间在台湾接受无泵冠状动脉旁路移植术(ONCAB)的1482名符合条件的冠状动脉疾病患者的长期生存率。23年累积全因死亡率为21.9%,累积心血管特异性死亡率(CVD)为2.09%。年龄≥70岁的患者全因死亡的发病率比(IRR)显著高于年龄≥70岁的患者(IRR, 2.183, 95%可信区间[CI], 1.742 ~ 2.731),但累积发病率比(CIRR, 0.634, 95% CI, 0.524 ~ 0.767)低于年龄≥70岁的患者;70年。两组CVD的IRR、CIRR比较,差异均无统计学意义。所有患者的总生存受到高血压(危险比[HR], 1.412, 95% CI, 1.104-1.806)、血脂异常(危险比,1.890,95% CI, 1.506-2.372)和既往卒中(危险比,0.525,95% CI, 0.391-0.705)的影响。我们的结果表明,ONCAB可能是老年患者的可行选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Long-term survival after on-pump coronary artery bypass grafting in patients with coronary artery disease in Taiwan

The study analyzed the long-term survival of 1,482 eligible patients with coronary artery disease who received on-pump coronary artery bypass grafting (ONCAB) between 1997 and 2003 in Taiwan. The cumulative all-cause death rate over 23 years was 21.9%, while the cumulative cardiovascular-specific death (CVD) rate was 2.09%. Patients aged ≥ 70 years had a significantly higher incidence rate ratio (IRR) (IRR, 2.183, 95% confidence interval [CI], 1.742–2.731), but the lower cumulative incidence rate ratio (CIRR) (CIRR, 0.634, 95% CI, 0.524–0.767) for all-cause deaths than those aged < 70 years. There was no significant difference for IRR and CIRR of CVD between 2 groups. Overall survival was influenced by hypertension (hazard ratio [HR], 1.412, 95% CI, 1.104–1.806), dyslipidemia (HR, 1.890, 95% CI, 1.506–2.372), and previous stroke (HR, 0.525, 95% CI, 0.391–0.705) in all patients. Our results suggest that ONCAB may be a viable option for older patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Aging and health research
Aging and health research Clinical Neurology, Public Health and Health Policy, Geriatrics and Gerontology
CiteScore
0.60
自引率
0.00%
发文量
0
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信